Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Trujillo

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Therapeutic Advances in Endocrinology and Metabolism|September 6, 2018
5-alpha-dihydrotestosterone elevations associated with phentermine useScott M Pearson, Jennifer M Trujillo, Michael T McDermott
American Journal of Pharmaceutical Education|July 18, 2024
A doctor of pharmacy curriculum revision process focused on curricular overloadJennifer M Trujillo, Sara A Wettergreen, David L Bain
Clinical Diabetes : a Publication of the American Diabetes Association|October 21, 2024
Erratum: Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clinical Diabetes 2023;41:467-473Heather P Whitley, Jennifer M Trujillo, Joshua J Neumiller
The Annals of Pharmacotherapy|June 23, 2018
Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 DiabetesRhianna M Tuchscherer, Angela M Thompson, Jennifer M Trujillo
American Journal of Pharmaceutical Education|May 7, 2026
A Crisis of Clarity: When Everyone is Ordering from a Different MenuKristine M Cline, Aleda M H Chen, Jennifer M Trujillo
Diabetes Spectrum : a Publication of the American Diabetes Association|February 23, 2023
Comparison of the Usability, Accuracy, Preference, and Satisfaction of Three Once-Weekly Glucagon-Like Peptide 1 Receptor Agonist Pen Devices in People With Type 2 DiabetesSara A Wettergreen, Morgan P Stewart, Katelyn Kennedy, et al.
Journal of the American Pharmacists Association : Japha|July 25, 2012
Determining predictors of response to exenatide in type 2 diabetesSarah L Anderson, Jennifer M Trujillo, Michael McDermott, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 26, 2023
Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic ReviewKeith C Ferdinand, Keith C Norris, Helena W Rodbard, et al.
Postgraduate Medicine|December 21, 2017
Switching basal insulins in type 2 diabetes: practical recommendations for health care providersSarah L Anderson, Jennifer M Trujillo, John E Anderson, et al.
BMJ Medicine|September 8, 2023
Advances in the management of type 2 diabetes in adultsRodolfo J Galindo, Jennifer M Trujillo, Cecilia C Low Wang, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Endocrinology and Metabolism|September 6, 2018
5-alpha-dihydrotestosterone elevations associated with phentermine useScott M Pearson, Jennifer M Trujillo, Michael T McDermott
American Journal of Pharmaceutical Education|July 18, 2024
A doctor of pharmacy curriculum revision process focused on curricular overloadJennifer M Trujillo, Sara A Wettergreen, David L Bain
Clinical Diabetes : a Publication of the American Diabetes Association|October 21, 2024
Erratum: Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clinical Diabetes 2023;41:467-473Heather P Whitley, Jennifer M Trujillo, Joshua J Neumiller
The Annals of Pharmacotherapy|June 23, 2018
Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 DiabetesRhianna M Tuchscherer, Angela M Thompson, Jennifer M Trujillo
American Journal of Pharmaceutical Education|May 7, 2026
A Crisis of Clarity: When Everyone is Ordering from a Different MenuKristine M Cline, Aleda M H Chen, Jennifer M Trujillo
Diabetes Spectrum : a Publication of the American Diabetes Association|February 23, 2023
Comparison of the Usability, Accuracy, Preference, and Satisfaction of Three Once-Weekly Glucagon-Like Peptide 1 Receptor Agonist Pen Devices in People With Type 2 DiabetesSara A Wettergreen, Morgan P Stewart, Katelyn Kennedy, et al.
Journal of the American Pharmacists Association : Japha|July 25, 2012
Determining predictors of response to exenatide in type 2 diabetesSarah L Anderson, Jennifer M Trujillo, Michael McDermott, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 26, 2023
Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic ReviewKeith C Ferdinand, Keith C Norris, Helena W Rodbard, et al.
Postgraduate Medicine|December 21, 2017
Switching basal insulins in type 2 diabetes: practical recommendations for health care providersSarah L Anderson, Jennifer M Trujillo, John E Anderson, et al.
BMJ Medicine|September 8, 2023
Advances in the management of type 2 diabetes in adultsRodolfo J Galindo, Jennifer M Trujillo, Cecilia C Low Wang, et al.
Pageof 6